Cargando…
Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101088/ https://www.ncbi.nlm.nih.gov/pubmed/32258955 http://dx.doi.org/10.1210/jendso/bvaa021 |
_version_ | 1783511547297923072 |
---|---|
author | Freda, Pamela U Bruce, Jeffrey N Khandji, Alexander G Jin, Zhezhen Hickman, Richard A Frey, Emily Reyes-Vidal, Carlos Otten, Marc Wardlaw, Sharon L Post, Kalmon D |
author_facet | Freda, Pamela U Bruce, Jeffrey N Khandji, Alexander G Jin, Zhezhen Hickman, Richard A Frey, Emily Reyes-Vidal, Carlos Otten, Marc Wardlaw, Sharon L Post, Kalmon D |
author_sort | Freda, Pamela U |
collection | PubMed |
description | CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. OBJECTIVE: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro- to macroadenoma included observational and surgical therapy. METHODS: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. RESULTS: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. CONCLUSIONS: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups. |
format | Online Article Text |
id | pubmed-7101088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71010882020-04-01 Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study Freda, Pamela U Bruce, Jeffrey N Khandji, Alexander G Jin, Zhezhen Hickman, Richard A Frey, Emily Reyes-Vidal, Carlos Otten, Marc Wardlaw, Sharon L Post, Kalmon D J Endocr Soc Clinical Research Article CONTEXT: Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected until mass effect symptoms develop. However, currently, head imaging is performed commonly for many other indications, which may increase incidental discovery of CNFPAs. Since current presentation and outcome data are based on older, retrospective series, a prospective characterization of a contemporary CNFPA cohort was needed. OBJECTIVE: To determine the prevalence of incidental presentation and hypopituitarism and its predictors in a CNFPA cohort that spanned 6 to 9 mm micro- to macroadenoma included observational and surgical therapy. METHODS: At enrollment in a prospective, observational study, 269 patients with CNFPAs were studied by history, examination, blood sampling, and pituitary imaging analysis and categorized into incidental or symptoms presentation groups that were compared. RESULTS: Presentation was incidental in 48.7% of patients and due to tumor symptoms in 51.3%. In the symptoms and incidental groups, 58.7% and 27.4% of patients had hypopituitarism, respectively, and 25% of patients with microadenomas had hypopituitarism. Many had unappreciated signs and symptoms of pituitary disease. Most tumors were macroadenomas (87%) and were larger in the symptoms than incidental and hypopituitary groups than in the eupituitary groups. The patients in the incidental group were older, and males were older and had larger tumors in both the incidental and symptoms groups. CONCLUSIONS: Patients with CNFPAs commonly present incidentally and with previously unrecognized hypopituitarism and symptoms that could have prompted earlier diagnosis. Our data support screening all large micro and macro-CNFPAs for hypopituitarism. Most patients with CNFPAs still have mass effect signs at presentation, suggesting the need for more awareness of pituitary disease. Our ongoing, prospective observation of this cohort will assess outcomes of these CNFPA groups. Oxford University Press 2020-02-18 /pmc/articles/PMC7101088/ /pubmed/32258955 http://dx.doi.org/10.1210/jendso/bvaa021 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Article Freda, Pamela U Bruce, Jeffrey N Khandji, Alexander G Jin, Zhezhen Hickman, Richard A Frey, Emily Reyes-Vidal, Carlos Otten, Marc Wardlaw, Sharon L Post, Kalmon D Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title | Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title_full | Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title_fullStr | Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title_full_unstemmed | Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title_short | Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study |
title_sort | presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101088/ https://www.ncbi.nlm.nih.gov/pubmed/32258955 http://dx.doi.org/10.1210/jendso/bvaa021 |
work_keys_str_mv | AT fredapamelau presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT brucejeffreyn presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT khandjialexanderg presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT jinzhezhen presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT hickmanricharda presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT freyemily presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT reyesvidalcarlos presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT ottenmarc presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT wardlawsharonl presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy AT postkalmond presentingfeaturesin269patientswithclinicallynonfunctioningpituitaryadenomasenrolledinaprospectivestudy |